Shares of Hikma Pharmaceuticals PLC (OTCMKTS:HKMPF – Get Free Report) traded down 7.9% on Thursday . The stock traded as low as $22.33 and last traded at $22.33. 204 shares changed hands during mid-day trading, an increase of 10% from the average session volume of 186 shares. The stock had previously closed at $24.25.
Hikma Pharmaceuticals Price Performance
The company has a 50-day moving average price of $24.22 and a two-hundred day moving average price of $23.70. The company has a debt-to-equity ratio of 0.47, a current ratio of 1.57 and a quick ratio of 0.90.
Hikma Pharmaceuticals Increases Dividend
The company also recently announced a dividend, which will be paid on Friday, May 3rd. Stockholders of record on Friday, March 22nd will be paid a $0.47 dividend. The ex-dividend date of this dividend is Wednesday, March 20th. This is an increase from Hikma Pharmaceuticals’s previous dividend of $0.25.
Hikma Pharmaceuticals Company Profile
Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. It operates through three segments: Injectables, Generics, and Branded. The Injectables segment provides generic injectable products primarily for use in hospitals.
Read More
- Five stocks we like better than Hikma Pharmaceuticals
- 3 Fintech Stocks With Good 2021 Prospects
- Comprehensive PepsiCo Stock Analysis
- Most Volatile Stocks, What Investors Need to Know
- CSX Co.: The Railroad Powering Ahead with an Earnings Beat
- What Are Dividends? Buy the Best Dividend Stocks
- Bear Market Funds to Watch This Year
Receive News & Ratings for Hikma Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hikma Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
